Science Explorer Back to mapMap
Discussion
Institution · Infectious Disease Consultants

Most cited papers from Infectious Disease Consultants

Infectious Disease Consultants

What are the most cited papers from Infectious Disease Consultants?

The most cited paper from Infectious Disease Consultants is "Indoleamine 2,3-dioxygenase and tumor-induced tolerance" (David H. Munn, Andrew L. Mellor, 2007), with 1,081 citations. Next come "Treating Clostridium difficile Infection With Fecal Microbiota Transplantation" (1,024) and "Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes" (851).

Showing 50 of 60 papers. Every paper with more than 176 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Indoleamine 2,3-dioxygenase and tumor-induced tolerance David H. Munn, Andrew L. Mellor · Journal of Clinical Investigation Open access May 2007 1,081
2 Treating Clostridium difficile Infection With Fecal Microbiota Transplantation Johan Bakken, Thomas Julius Borody, Lawrence J. Brandt et al. · Clinical Gastroenterology and Hepatology Open access 25 Aug 2011 1,024
3 Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes David H. Munn, Madhav D. Sharma, De‐Yan Hou et al. · Journal of Clinical Investigation Open access 15 Jul 2004 851
4 Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial Matteo Bassetti, ROGER M. ECHOLS, Yuko Matsunaga et al. · The Lancet Infectious Diseases 12 Oct 2020 832
5 Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease Israel Molina, Jordi Gómez i Prat, Fernando Salvador et al. · New England Journal of Medicine Open access 14 May 2014 628
6 First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA Isaac Ghinai et al. · The Lancet Open access 13 Mar 2020 624
7 Pathology and Pathogenesis of Severe Acute Respiratory Syndrome Jiang Gu, Christine Korteweg · American Journal Of Pathology Open access 27 Mar 2007 621
8 Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment Ali Hassoun, Peter K. Linden, Bruce C. Friedman · Critical Care Open access 14 Aug 2017 615
9 Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses De-Yan Hou, Alexander J. Muller, Madhav D. Sharma et al. · Cancer Research 15 Jan 2007 588
10 Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook Colleen R. Kelly, Stacy A. Kahn, Purna Kashyap et al. · Gastroenterology Open access 14 May 2015 578
11 A fully integrated microfluidic genetic analysis system with sample-in–answer-out capability Christopher John Easley, James M. Karlinsey, Joan M. Bienvenue et al. · Proceedings of the National Academy of Sciences Open access 12 Dec 2006 548
12 Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy Pablo Tebas, William G. Powderly, Sherry Claxton et al. · AIDS Open access Mar 2000 542
13 Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy Alan Douglas Tice, Susan J. Rehm, J. R. Dalovisio et al. · Clinical Infectious Diseases Open access 2 Jun 2004 534
14 Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial David A. Margolis et al. · The Lancet 24 Jul 2017 509
15 Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection Chloe M. Orkin et al. · New England Journal of Medicine Open access 4 Mar 2020 496
16 Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials Bonaventura Clotet, Nicholas Bellos, Jean‐Michel Molina et al. · The Lancet Apr 2007 486
17 Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial Richard G. Wunderink, Yuko Matsunaga, Mari Ariyasu et al. · The Lancet Infectious Diseases 12 Oct 2020 484
18 A critical role for the programmed death ligand 1 in fetomaternal tolerance Indira Guleria, Arezou Khosroshahi, Mohammed Javeed Ansari et al. · The Journal of Experimental Medicine Open access 18 Jul 2005 437
19 Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers Azad Rahimpour, Hui‐Fern Koay, Anselm Enders et al. · The Journal of Experimental Medicine Open access 22 Jun 2015 398
20 Practice Guidelines for the Management of Patients with Histoplasmosis Joseph L. Wheat, George A. Sarosi, D. S. McKinsey et al. · Clinical Infectious Diseases Open access Apr 2000 387
21 River Blindness: A Success Story under Threat? Marı́a-Gloria Basáñez, Sébastien D. S. Pion, Thomas S. Churcher et al. · PLoS Medicine Open access 19 Sep 2006 377
22 2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapya Anne H. Norris, Nabin K. Manandhar Shrestha, Geneve M. Allison et al. · Clinical Infectious Diseases Open access 13 Nov 2018 373
23 Abnormal Bactericidal, Metabolic, and Lysosomal Functions of Chediak-Higashi Syndrome Leukocytes Richard K. Root, Alan S. Rosenthal, Dominic J. Balestra · Journal of Clinical Investigation Open access Mar 1972 367
24 Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. C M Lilly, Hidetoshi Nakamura, H Kesselman et al. · Journal of Clinical Investigation Open access Apr 1997 367
25 Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection Gerd Fätkenheuer et al. · New England Journal of Medicine Open access Oct 2008 365
26 Endothelial Function Is Impaired across the Stages of the Menopause Transition in Healthy Women Kerrie L. Moreau, Kerry L. Hildreth, Amie L. Meditz et al. · The Journal of Clinical Endocrinology & Metabolism Open access 12 Sep 2012 355
27 CLINICAL PRESENTATION AND OUTCOME OF TUBERCULOSIS IN KIDNEY, LIVER, AND HEART TRANSPLANT RECIPIENTS IN SPAIN1 José María Aguado, José Antonio Herrero, Joan Gavald et al. · Transplantation May 1997 351
28 Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation Jia Jun Zhu, David M. Koelle, Jianhong Cao et al. · The Journal of Experimental Medicine Open access 26 Feb 2007 347
29 Infectious tolerance via the consumption of essential amino acids and mTOR signaling Stephen Paul Cobbold, Elizabeth J Adams, Claire A. Farquhar et al. · Proceedings of the National Academy of Sciences Open access 30 Jun 2009 336
30 Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection Sorana Segal‐Maurer, Edwin DeJesus, Hans‐Jürgen Stellbrink et al. · New England Journal of Medicine Open access 11 May 2022 329
31 Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials Joseph J. Eron et al. · The Lancet 2010 317
32 APOBEC3F Can Inhibit the Accumulation of HIV-1 Reverse Transcription Products in the Absence of Hypermutation Rebecca K. Holmes, Fransje A. Koning, Kate N. Bishop et al. · Journal of Biological Chemistry Open access 23 Nov 2006 309
33 Aminoglycoside Toxicity: Daily versus Thrice-Weekly Dosing for Treatment of Mycobacterial Diseases Charles A. Peloquin, Shaun E. Berning, Akihisa Nitta et al. · Clinical Infectious Diseases Open access 18 May 2004 272
34 Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. Mary Ann De Groote, Donald Granger, Yisheng Xu et al. · Proceedings of the National Academy of Sciences Open access 3 Jul 1995 251
35 The impact of war on the health system of the Tigray region in Ethiopia: an assessment Hailay Abrha Gesesew, Kiros T Berhane, Elias S. Siraj et al. · BMJ Global Health Open access Nov 2021 250
36 T cell suppression in transplantation tolerance through linked recognition Joanna Davida Davies, Louise Y. W. Leong, Andrew L. Mellor et al. · The Journal of Immunology May 1996 244
37 Functional expression of indoleamine 2,3-dioxygenase by murine CD8α+ dendritic cells Francesca Fallarino, Carmine Vacca, Ciriana Orabona et al. · International Immunology 2002 242
38 The Importance of Long-term Acute Care Hospitals in the Regional Epidemiology of Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae Michael Y. Lin et al. · Clinical Infectious Diseases Open access 14 Aug 2013 235
39 The Rising Challenge of Non-AIDS-Defining Cancers in HIV-Infected Patients John F. Deeken, A. Tjen-A-Looi, Michelle A. Rudek et al. · Clinical Infectious Diseases Open access 9 Jul 2012 231
40 A Gamma Interferon Independent Mechanism of CD4 T Cell Mediated Control of M. tuberculosis Infection in vivo Alena M. Gallegos, Jeroen W. J. van Heijst, Miriam Samstein et al. · PLoS Pathogens Open access 19 May 2011 226
41 Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults Sherene Min, Louis M. Sloan, Edwin DeJesus et al. · AIDS 30 Jun 2011 221
42 Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment Kimberly Y. Smith, Parul Patel, Derek Michael Fine et al. · AIDS 15 Jul 2009 217
43 Impact of Routine Infectious Diseases Service Consultation on the Evaluation, Management, and Outcomes of Staphylococcus aureus Bacteremia Timothy C Jenkins, Connie Savor Price, Allison Lee Sabel et al. · Clinical Infectious Diseases Open access 29 Feb 2008 216
44 Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry Colleen R. Kelly et al. · Gastroenterology Open access Oct 2020 214
45 A Conformational and Structure−Activity Relationship Study of Cytotoxic 3,5-Bis(arylidene)-4-piperidones and Related N-Acryloyl Analogues Jonathan Richard Dimmock, Maniyan P. Padmanilayam, Ramanan N. Puthucode et al. · Journal of Medicinal Chemistry 20 Jan 2001 214
46 Histoplasmosis After Solid Organ Transplant Maha Assi et al. · Clinical Infectious Diseases Open access 17 Sep 2013 212
47 Outbreak of Neurologic Enterovirus Type 71 Disease: A Diagnostic Challenge Carlos M. Pérez‐Vélez, Malcolm Anderson, Christine C. Robinson et al. · Clinical Infectious Diseases 27 Sep 2007 206
48 Infectious Diseases Specialty Intervention Is Associated With Decreased Mortality and Lower Healthcare Costs Steven K. Schmitt, Daniel P. McQuillen, Ronald Nahass et al. · Clinical Infectious Diseases 25 Sep 2013 201
49 Diagnostic and Prognostic Value of Clinical and Laboratory Findings in Cryptococcal Meningitis William T. Butler, David W. Alling, Anderson Spickard et al. · New England Journal of Medicine 9 Jan 1964 198
50 SOLO Joseph Gathe, Prudence Ive, Robin Wood et al. · AIDS Jul 2004 198

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.